Literature DB >> 28365331

On the duration of the period between exposure to HIV and detectable infection.

Bernhard P Konrad1, Darlene Taylor2, Jessica M Conway3, Gina S Ogilvie2, Daniel Coombs4.   

Abstract

HIV infection cannot be detected immediately after exposure because plasma viral loads are too small initially. The duration of this phase of infection (the "eclipse period") is difficult to estimate because precise dates of exposure are rarely known. Therefore, the reliability of clinical HIV testing during the first few weeks of infection is unknown, creating anxiety among HIV-exposed individuals and their physicians. We address this by fitting stochastic models of early HIV infection to detailed viral load records for 78 plasma donors, taken during the period of exposure and infection. We first show that the classic stochastic birth-death model does not satisfactorily describe early infection. We therefore apply a different stochastic model that includes infected cells and virions separately. Since every plasma donor in our data eventually becomes infected, we must condition the model to reflect this bias, before fitting to the data. Applying our best estimates of unknown parameter values, we estimate the mean eclipse period to be 8-10 days. We further estimate the reliability of a negative test t days after potential exposure.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eclipse period; HIV; Stochastic modelling; Viral kinetics

Mesh:

Year:  2017        PMID: 28365331     DOI: 10.1016/j.epidem.2017.03.002

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  8 in total

1.  Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Authors:  Gustavo H Kijak; Eric Sanders-Buell; Agnes-Laurence Chenine; Michael A Eller; Nilu Goonetilleke; Rasmi Thomas; Sivan Leviyang; Elizabeth A Harbolick; Meera Bose; Phuc Pham; Celina Oropeza; Kultida Poltavee; Anne Marie O'Sullivan; Erik Billings; Melanie Merbah; Margaret C Costanzo; Joanna A Warren; Bonnie Slike; Hui Li; Kristina K Peachman; Will Fischer; Feng Gao; Claudia Cicala; James Arthos; Leigh A Eller; Robert J O'Connell; Samuel Sinei; Lucas Maganga; Hannah Kibuuka; Sorachai Nitayaphan; Mangala Rao; Mary A Marovich; Shelly J Krebs; Morgane Rolland; Bette T Korber; George M Shaw; Nelson L Michael; Merlin L Robb; Sodsai Tovanabutra; Jerome H Kim
Journal:  PLoS Pathog       Date:  2017-07-31       Impact factor: 6.823

2.  Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment.

Authors:  Raabya Rossenkhan; Morgane Rolland; Jan P L Labuschagne; Roux-Cil Ferreira; Craig A Magaret; Lindsay N Carpp; Frederick A Matsen Iv; Yunda Huang; Erika E Rudnicki; Yuanyuan Zhang; Nonkululeko Ndabambi; Murray Logan; Ted Holzman; Melissa-Rose Abrahams; Colin Anthony; Sodsai Tovanabutra; Christopher Warth; Gordon Botha; David Matten; Sorachai Nitayaphan; Hannah Kibuuka; Fred K Sawe; Denis Chopera; Leigh Anne Eller; Simon Travers; Merlin L Robb; Carolyn Williamson; Peter B Gilbert; Paul T Edlefsen
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

Review 3.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure.

Authors:  Lauren M Kucirka; Stephen A Lauer; Oliver Laeyendecker; Denali Boon; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-05-13       Impact factor: 25.391

4.  Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.

Authors:  Morgane Rolland; Sodsai Tovanabutra; Bethany Dearlove; Yifan Li; Christopher L Owen; Eric Lewitus; Eric Sanders-Buell; Meera Bose; AnneMarie O'Sullivan; Raabya Rossenkhan; Jan Phillipus Lourens Labuschagne; Paul T Edlefsen; Daniel B Reeves; Gustavo Kijak; Shana Miller; Kultida Poltavee; Jenica Lee; Lydia Bonar; Elizabeth Harbolick; Bahar Ahani; Phuc Pham; Hannah Kibuuka; Lucas Maganga; Sorachai Nitayaphan; Fred K Sawe; Leigh Anne Eller; Robert Gramzinski; Jerome H Kim; Nelson L Michael; Merlin L Robb
Journal:  PLoS Pathog       Date:  2020-02-06       Impact factor: 6.823

5.  Evaluation of serological assays for the diagnosis of HIV infection in adults.

Authors:  Avania Bangalee; Sachin Bhoora; Rivak Punchoo
Journal:  S Afr Fam Pract (2004)       Date:  2021-10-25

6.  Timing HIV infection with a simple and accurate population viral dynamics model.

Authors:  Daniel B Reeves; Morgane Rolland; Bethany L Dearlove; Yifan Li; Merlin L Robb; Joshua T Schiffer; Peter Gilbert; E Fabian Cardozo-Ojeda; Bryan T Mayer
Journal:  J R Soc Interface       Date:  2021-06-30       Impact factor: 4.293

7.  'Break the Chains 2015' community-based HIV prevention campaign for men who have sex with men in Switzerland: non-randomised evaluation and cost analysis.

Authors:  Kathrin Frey; Stéphanie Lociciro; Raphael Bize; Daniel Kübler; Nicola Low; Patricia Blank; Matthias Schwenkglenks; Françoise Dubois-Arber; Rolf Rosenbrock; Andreas Lehner; Roger Staub; Steven Derendinger; Axel Schmidt
Journal:  BMJ Open       Date:  2020-01-21       Impact factor: 2.692

8.  Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.

Authors:  Daniel B Reeves; Yunda Huang; Elizabeth R Duke; Bryan T Mayer; E Fabian Cardozo-Ojeda; Florencia A Boshier; David A Swan; Morgane Rolland; Merlin L Robb; John R Mascola; Myron S Cohen; Lawrence Corey; Peter B Gilbert; Joshua T Schiffer
Journal:  PLoS Comput Biol       Date:  2020-02-21       Impact factor: 4.779

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.